This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34400871
rdf:type
wikibase:Item
schema:description
artigo científico (publicado na 2014) artículu científicu espublizáu en 2014 мақолаи илмӣ vedecký článok 2014年论文 tudományos cikk мақолаи илмӣ מאמר מדעי scienca artikolo مقالة علمية vetenskaplig artikel 2014年論文 2014年论文 article scientific naučni članak artikulong pang-agham tieteellinen artikkeli 2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած article scientifique (publié 2014) 2014년 논문 ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2014年论文 наукова стаття, опублікована у вересні 2014 wetenschappelijk artikel научна статия bài báo khoa học 2014年論文 2014年论文 سائنسی مضمون articolo scientifico επιστημονικό άρθρο научни чланак 2014年論文 2014 nî lūn-bûn სამეცნიერო სტატია 2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված vědecký článek bilimsel makale artigo científico (publicado na 2014) artículo científico publicado en 2014 scientific article 2014年论文 videnskabelig artikel (udgivet 2014) vitskapeleg artikkel научная статья artigo científico научни чланак 2014年論文 wissenschaftlicher Artikel 2014年论文 teaduslik artikkel articol științific artikull shkencor artykuł naukowy مقالهٔ علمی 2014年の論文 mokslinis straipsnis article científic 2014年論文 vitenskapelig artikkel บทความทางวิทยาศาสตร์
p:P577
wds:Q34400871-BCD84A4C-92C9-4729-946E-DE27700321E0
wdt:P577
2014-09-01T00:00:00Z
p:P2860
wds:Q34400871-C1FB7419-E0A3-4F15-9B6E-C8D3439CB251 wds:Q34400871-E032C9DE-0D01-457D-B169-205FBDD9780D wds:Q34400871-BF234DA6-8937-4693-9EA4-FD06FC45A3B2 wds:Q34400871-C1BA35F7-513B-475E-A849-7C84FAE1AADA wds:Q34400871-EBEB9998-378C-4FC8-98F7-CFF47CF7D367 wds:Q34400871-EF15367F-782A-40C8-9D06-7E7F6E66DD5C wds:Q34400871-4FA8FC39-72F6-4968-9CA6-FCA0F1EAC700 wds:Q34400871-2CD7DA07-0DD9-42FC-955E-F901F74B0E6E wds:Q34400871-33AC5F74-D300-4D88-81F2-1746B8FDEFAA wds:Q34400871-654B5D9B-3A0A-420E-9801-7C5EBDFC0400 wds:Q34400871-7B2CDC20-8E31-4690-88F9-EAF9694C6D46 wds:Q34400871-8F4CB5C0-53DA-4F57-8145-3728507BB61E wds:Q34400871-0C9E4459-C496-4095-A5DE-28B0118B794C wds:Q34400871-23DAD842-2C51-415A-A2CA-1B32E0E21BD1
wdt:P2860
wd:Q46722599 wd:Q34432003 wd:Q34741065 wd:Q35013008 wd:Q38009690 wd:Q46674433 wd:Q42808862 wd:Q55055148 wd:Q28274454 wd:Q57630939 wd:Q43095846 wd:Q46674427 wd:Q46674422 wd:Q30425097
p:P2093
wds:Q34400871-425F44FB-59FB-4D19-97CB-763BED0B5906 wds:Q34400871-2E7D5847-1BA0-4FC4-A1DF-D2D969AF5DD4 wds:Q34400871-8ACCB039-17C4-49E1-A6FD-14BC6564A864 wds:Q34400871-A0A1CA8F-0E0D-4F02-A99B-58AD14EA731F wds:Q34400871-DB1F6B71-0E6B-4532-832D-976A3743B9A4
wdt:P2093
Susan B Garavaglia Rebecca Levin Haik Novshadian Sharon G Frazee Glen Stettin
rdfs:label
Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010. Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010. Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.
skos:prefLabel
Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010. Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010. Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.
schema:name
Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010. Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010. Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.
p:P50
wds:Q34400871-AE032343-9B63-4776-B1B2-FCD7DB5D21A1 wds:Q34400871-573360A0-5C18-437A-B1C0-584CAA39A7B1 wds:Q34400871-5FBA5ED2-C8EA-4A98-B40D-EAE5B1E01A87
wdt:P50
wd:Q92575259 wd:Q28211478 wd:Q42409824
p:P1476
wds:Q34400871-B60A4697-32C6-4B18-8842-2A681B4EA98E
wdt:P1476
Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.
p:P304
wds:Q34400871-0EA46762-D35D-40EF-862A-536C7D1BFE00
wdt:P304
1486-1493
p:P31
wds:Q34400871-2B34445D-B4E8-4956-9CC7-3DCC04C7416C
wdt:P31
wd:Q13442814
p:P698
wds:Q34400871-F1AD6092-E783-4A7C-BEB5-3855C22B5961
wdtn:P698
n12:25070672
wdt:P698
25070672
p:P1433
wds:Q34400871-EFA46668-046C-45E9-A822-27AE7872E287
wdt:P1433
wd:Q177428
p:P433
wds:Q34400871-9ADEA0A2-0EBB-4DBA-BA09-CE8CBBD028B1
p:P478
wds:Q34400871-E8B1EA1F-9901-46E1-853C-EE4FB3517927
wdt:P433
9
wdt:P478
174
p:P356
wds:Q34400871-4B5C2240-A842-44D2-9A75-4F4792F60E37
wdtn:P356
n11:JAMAINTERNMED.2014.3404
wdt:P356
10.1001/JAMAINTERNMED.2014.3404
p:P932
wds:Q34400871-C07D69F7-CCAC-4D94-860A-5B8BE1135CC2
wdt:P932
4208827